Selective Bibliography of Dr. Laura Schmidt 
Basic Science Program Directorate, NCI  

"Understanding genetics of and pathway dysregulation in kidney cancer: Insights into potential therapies from in vivo tumor models"

Wednesday, May 24, 2023

1.  Lang M, Schmidt LS, Wilson KM, Ricketts CJ, Sourbier C, Vocke CD, Wei D, Crooks DR, Yang Y, Gibbs BK, Zhang X, Klumpp-Thomas C, Chen L, Guha R, Ferrer M, McKnight C, Itkin Z, Wangsa D, Wangsa D, James A, Difilippantonio S, Karim B, Morís F, Ried T, Merino MJ, Srinivasan R, Thomas CJ, Linehan WM
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
Journal of Experimental & Clinical Cancer Research 42 (1):99 Apr 25 2023

2.  Di Malta C, Zampelli A, Granieri L, Vilardo C, De Cegli R, Cinque L, Nusco E, Pece S, Tosoni D, Sanguedolce F, Sorrentino NC, Merino MJ, Nielsen D, Srinivasan R, Ball MW, Ricketts CJ, Vocke CD, Lang M, Karim B, Lanfrancone L, Schmidt LS, Linehan WM, Ballabio A
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
EMBO Molecular Medicine e16877 Mar 29 2023

3.  Vocke CD, Fleming LR, Piskorski AM, Amin A, Phornphutkul C, de la Monte S, Vilboux T, Duncan F, Pellegrino J, Braddock B, Middelton LA, Schmidt LS, Merino MJ, Cowen EW, Introne WJ, Linehan WM, Smith ACM
A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening
American Journal of Medical Genetics Part A 191 (2):490-497 Feb 2023

4.  Chen JL, Miller DT, Schmidt LS, Malkin D, Korf BR, Eng C, Kwiatkowski DJ, Giannikou K
Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk
Annual Review of Genomics and Human Genetics 23 331-361 Aug 31 2022

5.  Lang M, Vocke CD, Ricketts CJ, Metwalli AR, Ball MW, Schmidt LS, Linehan WM
Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma
Urology 149 89-97 Mar 2021

6.  Carbone M, Arron ST, Beutler B, Bononi A, Cavenee W, Cleaver JE, Croce CM, D'Andrea A, Foulkes WD, Gaudino G, Groden JL, Henske EP, Hickson ID, Hwang PM, Kolodner RD, Mak TW, Malkin D, Monnat RJ, Jr., Novelli F, Pass HI, Petrini JH, Schmidt LS, Yang H
Tumour predisposition and cancer syndromes as models to study gene-environment interactions
Nature Reviews Cancer 20 (9):533-549 Sep 2020

7.  Endoh M, Baba M, Endoh T, Hirayama A, Nakamura-Ishizu A, Umemoto T, Hashimoto M, Nagashima K, Soga T, Lang M, Schmidt LS, Linehan WM, Suda T
A FLCN-TFE3 Feedback Loop Prevents Excessive Glycogenesis and Phagocyte Activation by Regulating Lysosome Activity
Cell Reports 30 (6):1823-1834.e5 Feb 11 2020

8.  Linehan WM, Schmidt LS, Crooks DR, Wei D, Srinivasan R, Lang M, Ricketts CJ
The Metabolic Basis of Kidney Cancer
Cancer Discovery 9 (8):1006-1021 Aug 2019

9.  Baba M, Furuya M, Motoshima T, Lang M, Funasaki S, Ma W, Sun HW, Hasumi H, Huang Y, Kato I, Kadomatsu T, Satou Y, Morris N, Karim BO, Ileva L, Kalen JD, Wilan Krisna LA, Hasumi Y, Sugiyama A, Kurahashi R, Nishimoto K, Oyama M, Nagashima Y, Kuroda N, Araki K, Eto M, Yao M, Kamba T, Suda T, Oike Y, Schmidt LS, Linehan WM
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease
Molecular Cancer Research 17 (8):1613-1626 Aug 2019

10.  Schmidt LS, Linehan WM
FLCN: The causative gene for Birt-Hogg-Dubé syndrome
Gene 640 28-42 Jan 15 2018